Top 9 search results for "Adcetris" in Resources. To see all results and access other features, sign up for free.

... Other targeted therapy drugs such as Adcetris (brentuximab vedotin) and Folotyn (pralatrexate) may also be used.Clinical TrialsOngoing clinical trials for AITL treatment using existing and experimental drugs may be another option for treatment. Clinical trials test the effectiveness of various drugs, sometimes in conjunction with chemotherapy. ...

... Another immunotherapy drug, Adcetris (brentuximab vedotin), may also be used for relapsed or refractory disease or for newly diagnosed stage 3 or stage 4 cHL.Other cHL Treatment OptionsPeople with relapsed or refractory cHL may need different treatment plans that consist of higher treatment doses or other medications. ...

... doxorubicin (also known as hydroxydaunorubicin and sold as Adriamycin, and prednisone (a corticosteroid)CHOEP — Cyclophosphamide, doxorubicin, vincristine sulfate (formally sold as Oncovin), etoposide (also known as VP-16), and prednisoneCHOP — Cyclophosphamide, doxorubicin, vincristine sulfate, and prednisoneTargeted immunotherapy for ALCL may include Adcetris ...

... Spelled out, ABVD includes the medications: Doxorubicin (Adriamycin or Rubex) Bleomycin (Blenoxane) Vinblastine (Velbane) Dacarbazine (DTIC-Dome) Newer drugs that can also be used include: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Brentuximab (Adcetris) In cases that are more difficult to treat, a person with LRHL may undergo a stem cell transplant ...

... Examples include: Brentuximab vedotin (Adcetris) — Approved for people with some types of Hodgkin or non-Hodgkin lymphoma Loncastuximab tesirine (Zynlonta) — Used to treat some people with relapsed or refractory large B-cell lymphoma Polatuzumab vedotin (Polivy) — Used to treat some cases of NHL CD20xCD3 bispecific antibodies are a new type of targeted ...

... Brentuximab vedotin (Adcetris) has been used to treat advanced cutaneous T-cell lymphoma. It works by targeting an antigen found on cancerous T cells. Chemotherapy While often used in combination to treat other cancers, chemotherapy agents are often used as “single agents” — one at a time — to treat cutaneous T-cell lymphoma. ...

... Some of the chemotherapy drugs most likely to cause CIPN include: Brentuximab vedotin (Adcetris) Vincristine (formerly sold as Oncovin) bortezomib (Velcade) Platinum-based drugs like cisplatin (Platinol) and carboplatin (Paraplatin) CIPN develops in 30 percent to 40 percent of people who undergo cancer treatment. ...

... Examples of ADCs used in large B-cell lymphoma include: Brentuximab vedotin (Adcetris) — This may be used in select relapsed/refractory LBCL cases, depending on lab testing of the lymphoma cells (such as whether they carry certain markers) and which treatments the person has already had. It’s typically given as part of a combination regimen. ...

... Examples of ADCs include: Brentuximab vedotin (Adcetris) Loncastuximab tesirine-lpyl (Zynlonta) Polatuzumab vedotin-piiq (Polivy) Immune Checkpoint InhibitorsImmune checkpoint inhibitors are drugs that strengthen the immune system’s response to cancer cells. Normally, the immune system uses checkpoint proteins to keep from attacking healthy cells. ...